Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Successful drug development is contingent on choosing biologic models and tools for the development of biomarkers to evaluate therapy responsiveness. NGS-based biomarkers have transformed precision medicine to date, however, emerging tools such as single cell sequencing, spatial transcriptomics, RNA sequencing, whole genome sequencing, CRISPR, and cancer tissue AI are emerging technologies to propel the next generation of cancer therapeutics. See what is under the hood.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Dig into the research behind this topic — plain-English summaries written for BCBAs.
280 research articles with practitioner takeaways
239 research articles with practitioner takeaways
232 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.